1. Home
  2. Labeler Index
  3. Celltrion Usa, Inc.
  4. 72606-015
  5. NDC Package Code: 72606-015-01 Deferasirox

NDC Package 72606-015-01 Deferasirox

View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
72606-015-01
Package Description:
30 TABLET, FILM COATED in 1 BOTTLE
Product Code:
72606-015
Proprietary Name:
Deferasirox
Usage Information:
This medication is used to treat ongoing high levels of iron in the body caused by multiple blood transfusions. It is also used to treat high levels of iron in people with a certain blood disorder who do not require blood transfusions (non-transfusion-dependent thalassemia). It works by binding to iron, allowing the body to pass extra iron out in the stool. Deferasirox belongs to a class of drugs known as iron-chelating agents. Frequent blood transfusions are often needed in certain types of blood diseases (such as sickle cell disease, anemia). Blood transfusions have very helpful benefits, but they can cause the body to hold on to too much iron. The extra iron can build up in the body and cause problems such as heart failure, liver disease, and diabetes. Getting rid of extra iron can decrease the risk of these diseases.
11-Digit NDC Billing Format:
72606001501
Labeler Name:
Celltrion Usa, Inc.
Sample Package:
No
FDA Application Number:
ANDA212669
Marketing Category:
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date:
06-08-2021
End Marketing Date:
05-30-2023
Listing Expiration Date:
05-30-2023
Exclude Flag:
D
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 72606-015-01?

The NDC Packaged Code 72606-015-01 is assigned to a package of 30 tablet, film coated in 1 bottle of Deferasirox, labeled by Celltrion Usa, Inc.. The product's dosage form is and is administered via form.

Is NDC 72606-015 included in the NDC Directory?

No, Deferasirox with product code 72606-015 is excluded from the NDC Directory because it was discontinued by the manufacturer. The product was first marketed by Celltrion Usa, Inc. on June 08, 2021 and its listing in the NDC Directory is set to expire on May 30, 2023 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 72606-015-01?

The 11-digit format is 72606001501. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-272606-015-015-4-272606-0015-01